Add to ORKGTo evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy
Background: The rapid progression of Coronavirus disease 2019 (COVID-19) and its increasing burden o...
The current COVID-19 pandemic challenges not only the lack of awareness of the disease, but also the...
COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasi...
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis o...
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis o...
The outbreak of SARS-CoV-2 began in December 2019 and rapidly became a pandemic. The present study i...
The Coronavirus infectious disease 2019 (COVID-19) has recently emerged as a pandemic and has endang...
Lymphopenia is commonly present in patients with COVID-19. We sought to determine if lymphopenia on ...
OBJEKTIVE: Evidence-based characterization of the diagnostic and prognostic value of the hematologic...
COVID-19 may appear with a widely heterogeneous clinical expression. Thus, predictive markers of the...
Introduction: Coronavirus disease 2019 (Covid‐19) is a predominantly respiratory illness caused by t...
Objectives:. The neutrophil-lymphocyte ratio is an inexpensive and simple inflammatory marker. A hig...
Aims: This study aimed to make a comparison between the clinical laboratory-related factors, complet...
Background: The rapid progression of Coronavirus disease 2019 (COVID-19) and its increasing burden o...
Abstract Background and Aims Predicting severe disease is important in provocative decision‐making f...
Background: The rapid progression of Coronavirus disease 2019 (COVID-19) and its increasing burden o...
The current COVID-19 pandemic challenges not only the lack of awareness of the disease, but also the...
COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasi...
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis o...
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis o...
The outbreak of SARS-CoV-2 began in December 2019 and rapidly became a pandemic. The present study i...
The Coronavirus infectious disease 2019 (COVID-19) has recently emerged as a pandemic and has endang...
Lymphopenia is commonly present in patients with COVID-19. We sought to determine if lymphopenia on ...
OBJEKTIVE: Evidence-based characterization of the diagnostic and prognostic value of the hematologic...
COVID-19 may appear with a widely heterogeneous clinical expression. Thus, predictive markers of the...
Introduction: Coronavirus disease 2019 (Covid‐19) is a predominantly respiratory illness caused by t...
Objectives:. The neutrophil-lymphocyte ratio is an inexpensive and simple inflammatory marker. A hig...
Aims: This study aimed to make a comparison between the clinical laboratory-related factors, complet...
Background: The rapid progression of Coronavirus disease 2019 (COVID-19) and its increasing burden o...
Abstract Background and Aims Predicting severe disease is important in provocative decision‐making f...
Background: The rapid progression of Coronavirus disease 2019 (COVID-19) and its increasing burden o...
The current COVID-19 pandemic challenges not only the lack of awareness of the disease, but also the...
COVID-19 is a systemic infection with a significant impact on the hematopoietic system and hemostasi...